Decline in Prostate Cancer Screening by Primary Care Physicians: An Analysis of Trends in the Use of Digital Rectal Examination and Prostate Specific Antigen Testing.

PURPOSE Prostate cancer screening by digital rectal examination and prostate specific antigen testing has been routine clinical practice in the United States for the last 25 years. Recent studies have shown a national decline in prostate specific antigen testing following the USPSTF (United States Preventive Services Task Force) recommendation against routine prostate specific antigen screening. However, to our knowledge the effect of this recommendation on digital rectal examination utilization remains unknown. MATERIALS AND METHODS We used NAMCS (National Ambulatory Medical Care Survey) to characterize trends in the rate of digital rectal examination and prostate specific antigen testing by primary care physicians in men older than 40 years presenting for preventive care. From 2005 to 2012 NAMCS contained 3,368 such visits (unweighted) for the study of digital rectal examination trends and 4,035 unweighted visits from 2002 to 2012 for the study of prostate specific antigen trends. RESULTS Following the USPSTF recommendation the proportion of visits where digital rectal examination was performed decreased from 16.0% (95% CI 13.1-19.5) to 5.8% (95% CI 4.0-8.3, p <0.001). Similarly, the proportion of visits where prostate specific antigen testing was performed decreased from 27.3% (95% CI 24.5-30.3) to 16.7% (95% CI 12.9-21.2, p <0.001). This represents a relative 64% decrease in digital rectal examination and a 39% decrease in prostate specific antigen testing. Among men 55 to 69 years old the number of visits where digital rectal examination and prostate specific antigen testing were performed decreased 65% and 39%, respectively (p <0.001). CONCLUSIONS Utilization of digital rectal examination and prostate specific antigen has declined significantly following the release of the USPSTF recommendation against prostate specific antigen screening. This suggests that prostate cancer screening is rapidly disappearing from primary care practice.

[1]  S. Eggener,et al.  National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  G. Chodak,et al.  Early detection of prostate cancer by routine screening. , 1984, JAMA.

[3]  P Carlsson,et al.  Screening for carcinoma of the prostate by digital rectal examination in a randomly selected population. , 1990, BMJ.

[4]  T. Ludvigsen,et al.  Digital rectal examination to screen for prostatic cancer. , 1988, European urology.

[5]  I. Thompson,et al.  Impact of routine screening for adenocarcinoma of the prostate on stage distribution. , 1987, The Journal of urology.

[6]  John D. Massman,et al.  Prostate Needle Biopsy Outcomes in the Era of the U.S. Preventive Services Task Force Recommendation against Prostate Specific Antigen Based Screening. , 2016, The Journal of urology.

[7]  W. Catalona,et al.  Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.

[8]  J. Richie,et al.  COMPARISON OF DIGITAL RECTAL EXAMINATION AND SERUM PROSTATE SPECIFIC ANTIGEN IN THE EARLY DETECTION OF PROSTATE CANCER: RESULTS OF A MULTICENTER CLINICAL TRIAL OF 6,630 MEN , 1994, The Journal of urology.

[9]  P. Dahm,et al.  Screening for prostate cancer. , 2013, The Cochrane database of systematic reviews.

[10]  V. Moyer,et al.  Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.

[11]  Christopher J Kane,et al.  Prostate Cancer, Version 1.2016. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[12]  G. Chodak,et al.  Assessment of screening for prostate cancer using the digital rectal examination. , 1989, The Journal of urology.

[13]  D. Penson.  The Pendulum of Prostate Cancer Screening. , 2015, JAMA.

[14]  Sam S. Chang,et al.  Effect of the USPSTF Grade D Recommendation against Screening for Prostate Cancer on Incident Prostate Cancer Diagnoses in the United States. , 2015, The Journal of urology.

[15]  P. Guinan,et al.  The accuracy of the rectal examination in the diagnosis of prostate carcinoma. , 1980, The New England journal of medicine.

[16]  I. Thompson,et al.  Current status of lymph node‐positive prostate cancer , 2006, Cancer.

[17]  I. Thompson,et al.  Disease-specific survival following routine prostate cancer screening by digital rectal examination. , 1993, JAMA.

[18]  R. Kane,et al.  The relationship of prostate‐specific antigen to digital rectal examination and transrectal ultrasonography: Findings of the American cancer society national prostate cancer detection project , 2010, Cancer.

[19]  A. Jemal,et al.  Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations. , 2015, JAMA.

[20]  Mohammad Hassan Murad,et al.  Early detection of prostate cancer: AUA Guideline. , 2013, The Journal of urology.

[21]  P. Kantoff,et al.  Prostate-Specific Antigen Screening After 2012 US Preventive Services Task Force Recommendations. , 2015, JAMA.

[22]  Dante diTommaso,et al.  Quantifying the role of PSA screening in the US prostate cancer mortality decline , 2008, Cancer Causes & Control.